Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Gynecologic Oncology|June 28, 2005
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancerGabriella Ferrandina, Franco Oreste Ranelletti, Valerio Gallotta, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2015
Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective studyCristina Sigismondi, Paolo Scollo, Gabriella Ferrandina, et al.
Human Reproduction (Oxford, England)|June 28, 2005
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosisFrancesco Fanfani, Anna Fagotti, Gabriella Ferrandina, et al.
BMC Cancer|March 20, 2013
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosisGiovanna Mantegna, Marco Petrillo, Gilda Fuoco, et al.
Annals of Translational Medicine|January 25, 2021
Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literatureLuigi Carlo Turco, Gabriella Ferrandina, Virginia Vargiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patientsGabriella Ferrandina, Gian Franco Zannoni, Enrica Martinelli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 13, 2010
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinomaGiovanni Almadori, Francesco Bussu, Marco Gessi, et al.
American Journal of Obstetrics and Gynecology|September 20, 2008
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinomaAnna Fagotti, Gabriella Ferrandina, Francesco Fanfani, et al.
Fertility and Sterility|October 23, 2020
Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot studyRosa de Vincenzo, Caterina Ricci, Francesco Fanfani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National SurveyGabriella Ferrandina, Giulia Amadio, Ida Paris, et al.
Pageof 30